Literature DB >> 8325347

In vivo enhancement of the specific antibody response via the low-affinity receptor for IgE.

B Heyman1, L Tianmin, S Gustavsson.   

Abstract

The ability of antigen-specific IgE antibodies to modulate the in vivo antibody response was studied by comparing the antibody response in mice immunized with 2,4,6-trinitrophenyl (TNP)-specific monoclonal IgE followed by bovine serum albumin (BSA)-TNP or with BSA-TNP alone. The serum IgG antibody response against BSA, measured in enzyme-linked immunosorbent assay ELISA, was enhanced up to 100-fold in groups receiving IgE. The enhancement required specific interaction between IgE and antigen, since no effect was seen when unconjugated BSA was used as antigen. Polyclonal activation by IgE/antigen complexes did not occur. IgE given 24 h after specific antigen had no stimulatory capacity. Pretreatment of the mice with Fc epsilon receptor type II (Fc epsilon RII)-specific monoclonal antibody completely inhibited the IgE-mediated enhancement. Thus, the data demonstrate for the first time an in vivo role for Fc epsilon RII in enhancement of specific antibody production.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8325347     DOI: 10.1002/eji.1830230754

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  18 in total

Review 1.  IgE in asthma and atopy: cellular and molecular connections.

Authors:  H C Oettgen; R S Geha
Journal:  J Clin Invest       Date:  1999-10       Impact factor: 14.808

Review 2.  Functions of antibodies in the regulation of B cell responses in vivo.

Authors:  B Heyman
Journal:  Springer Semin Immunopathol       Date:  2001-12

3.  Efficient IgG-mediated suppression of primary antibody responses in Fcgamma receptor-deficient mice.

Authors:  M C Karlsson; S Wernersson; T Diaz de Ståhl; S Gustavsson; B Heyman
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-02       Impact factor: 11.205

4.  IgA attenuates anaphylaxis and subsequent immune responses in mice: possible application of IgA to vaccines.

Authors:  Kouya Yamaki; Takayuki Nakashima; Kenji Miyatake; Yuki Ishibashi; Ayaka Ito; Ayu Kuranishi; Akihito Taguchi; Ayumi Morioka; Midori Yamamoto; Shin Yoshino
Journal:  Immunol Res       Date:  2014-01       Impact factor: 2.829

5.  FcepsilonRI-mediated antigen endocytosis turns interferon-gamma-treated mouse mast cells from inefficient into potent antigen-presenting cells.

Authors:  C Tkaczyk; I Villa; R Peronet; B David; S Mécheri
Journal:  Immunology       Date:  1999-06       Impact factor: 7.397

6.  IgE/antigen-mediated enhancement of IgE production is a mechanism underlying the exacerbation of airway inflammation and remodelling in mice.

Authors:  Nobuaki Mizutani; Takeshi Nabe; Shin Yoshino
Journal:  Immunology       Date:  2015-01       Impact factor: 7.397

7.  The absence of IgE antibody-mediated augmentation of immune responses in CD23-deficient mice.

Authors:  H Fujiwara; H Kikutani; S Suematsu; T Naka; K Yoshida; K Yoshida; T Tanaka; M Suemura; N Matsumoto; S Kojima
Journal:  Proc Natl Acad Sci U S A       Date:  1994-07-19       Impact factor: 11.205

Review 8.  Immunoglobulin E, what is it good for?

Authors:  Brian T Kelly; Mitchell H Grayson
Journal:  Ann Allergy Asthma Immunol       Date:  2016-03       Impact factor: 6.347

Review 9.  Fifty years later: Emerging functions of IgE antibodies in host defense, immune regulation, and allergic diseases.

Authors:  Hans C Oettgen
Journal:  J Allergy Clin Immunol       Date:  2016-06       Impact factor: 10.793

10.  Specific antigen targeting to surface IgE and IgG on mouse bone marrow-derived mast cells enhances efficiency of antigen presentation.

Authors:  C Tkaczyk; M Viguier; Y Boutin; P Frandji; B David; J Hébert; S Mécheri
Journal:  Immunology       Date:  1998-07       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.